TY - JOUR
T1 - Topical Atropine in the Control of Myopia.
AU - Camacho López, Paul Anthony
PY - 2016/1/1
Y1 - 2016/1/1
N2 - Atropine has been used for more than a century to arrest myopia progression. Compelling evidence of its protective effect has been reported in well-designed clinical studies, mainly performed during the last two decades. However, its exact mechanism of action has not been determined. Experimental findings have shown that the mechanism is not related to accommodation, as was thought for decades. A review of the published literature revealed a significant amount of evidence supporting its safety and efficacy at a concentration of 1.0%, and at lower concentrations (as low as 0.01%).
AB - Atropine has been used for more than a century to arrest myopia progression. Compelling evidence of its protective effect has been reported in well-designed clinical studies, mainly performed during the last two decades. However, its exact mechanism of action has not been determined. Experimental findings have shown that the mechanism is not related to accommodation, as was thought for decades. A review of the published literature revealed a significant amount of evidence supporting its safety and efficacy at a concentration of 1.0%, and at lower concentrations (as low as 0.01%).
UR - https://europepmc.org/articles/PMC5347209
M3 - Artículo Científico
C2 - 28293653
JO - Medical hypothesis, discovery & innovation ophthalmology journal
JF - Medical hypothesis, discovery & innovation ophthalmology journal
ER -